Ledger.Open graph →
SEC Form D · Amendment · filed November 15, 2017

AZTherapies, INC

Offering
$7.6M
Sold
$6.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

John S. Porter · BOSTON, MADirectorPeter S. Conti · BOSTON, MADirectorRobert S. Warren · BOSTON, MAExecDavid S. Taft · BOSTON, MADirectorDavid R. Elmaleh · BOSTON, MAExec · DirectorRonald S. Tompkins · BOSTON, MADirectorKeith S. Greenfield · BOSTON, MAExec · DirectorGavin Cooper · Vancouver, British Columbia, CanadaDirectorRick Morgenstern · Boca Raton, FLExec · DirectorMox Weber · Boca Raton, FLExec · DirectorSean D. Otoole · Atlanta, GADirectorJoseph Brock · Boca Raton, FLDirectorRobert Greenberg · Boca Raton, FLExecMiguel Bilbao · New York, NYDirectorRobert Duncan · Vancouver, British Columbia, CanadaDirectorEric Stoppenhagen · Fremont, CADirectorJay Sujir · Vancouver, British Columbia, CanadaDirectorLarry R. Lancaster, Jr · Santa Clara, CAExec · DirectorAjay Singh · Santa Clara, CADirectorPatrick W. Keene · ST. PAUL, MNExec · DirectorAEI Trust Manager, LLC · ST. PAUL, MNExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗